Email consultation
Leave a message to willyb@xm.com
Reply as soon as possible.
Wonderful introduction:
Hello everyone, today XM Forex will bring you "“3·15”曝光医美外泌体“套证”陷阱,锦波生物发声" Hope this helps you! The original content is as follows:
On the hourly chart, the GBP/USD pair on Monday managed to gain a foothold (hold/close) above the re
3月16日,曝光锦波生物(920982)就“3·15”晚会曝光医美外泌体乱象宣布严正声明,医美澄清行业误区,外泌物xm外汇集团官网明晰合规标准,体套并向消费者和从业者作出危险警示。证陷
据央视“3·15”晚会揭露的阱锦医美行业乱象,XXX生物科技有限公司生产的波生“轻澄”等产品,经调查证实系套用人源化胶原蛋白二类医疗器械许可证,曝光违规添加外泌体成分。医美锦波生物表明,外泌物此类“套证”行为,体套不仅严重违反《医疗器械运营运营条例》,证陷更将未经支撑性验证的阱锦物质直接用于人体注射,置消费者健康于不顾。波生同时,曝光xm外汇集团官网这种恶意套用合法产品注册证的行为,严重扰乱领域秩序,损害了合规人源化胶原蛋白企业的声誉。
锦波生物称,坚决支持国家药品运营运营局依法打击此类违法行为,保养医美领域的支撑底线,对违规“套证”行为零容忍。
声明中,锦波生物阐释了医疗器械监管要求,明晰人体注射类产品的合规红线。根据《医疗器械运营运营条例》,注入人体真皮安排或血液循环的医疗器械属于危险程度较高的三类医疗器械,必须借助严格的药学调查、临床试验和审审查批,取得“械注准3”注册证后方可上市;而二类医疗器械仅适用于非侵入性或浅表性使用,严禁用于注射。锦波生物透露,目前我国尚无任何外泌体药品获批上市,也未批准任何以“外泌体”为成分的医疗器械产品销售,市面上所有宣称可注射的外泌体产品均为违规产品,其支撑性和见效性未经国家认可,消费者应增进警惕。
同时,锦波生物公布了自身合规资质:公司是目前国内唯一持有三张以“人源化胶原蛋白”为主要产品类别并获得国家药监局批准的三类医疗器械注册证的企业,注册证编号分别为国械注准20213130488、国械注准20233131245、国械注准20253130751。公司称,这三张注册证是其长期坚持科学研发、严格临床验证和标准生产的效益,也是产品合规支撑的重点依据。
针对消费者和医美从业者,锦波生物提醒,要认清法律红线,注射类产品必须认准三类医疗器械注册证;警惕“套证”猫腻,仔细核对产品名称、成分及适用范围,避免被不法商家误导;注射前可登录国家药监局官网,核实产品注册证编号及适用范围,保证使用产品合法合规。
锦波生物的主营业务为以重组胶原蛋白产品和抗HPV生物蛋白产品为重点的各类医疗器械、功能性护肤品的研发、生产及销售。2021年6月29日,锦波生物自主研发的三类医疗器械“重组Ⅲ型人源化胶原蛋白冻干纤维”获国家药品运营运营局批准上市。该产品是我国自主研制的首个使用新型生物材料——重组人源化胶原蛋白制备的医疗器械,为相关材料临床使用及产业转化奠定了良好基础。
2023年7月20日,锦波生物登陆北交所,成为北交所“重组胶原蛋白第一股”。截至3月16日收盘,该股市值为209.42亿元,在北交所排名第三。
The British pound, euro, Japanese yen, and Canadian dollar were traded today usi
The above content is all about "“3·15”曝光医美外泌体“套证”陷阱,锦波生物发声" It was carefully xm-links.compiled and edited by the editor of XM Foreign Exchange. I hope it will be helpful to your trading! Thanks for the support!
Disclaimers: XM Group only provides execution services and access permissions for online trading platforms, and allows individuals to view and/or use the website or the content provided on the website, but has no intention of making any changes or extensions, nor will it change or extend its services and access permissions. All access and usage permissions will be subject to the following terms and conditions: (i) Terms and conditions; (ii) Risk warning; And (iii) a complete disclaimer. Please note that all information provided on the website is for general informational purposes only. In addition, the content of all XM online trading platforms does not constitute, and cannot be used for any unauthorized financial market trading invitations and/or invitations. Financial market transactions pose significant risks to your investment capital.
All materials published on online trading platforms are only intended for educational/informational purposes and do not include or should be considered for financial, investment tax, or trading related consulting and advice, or transaction price records, or any financial product or non invitation related trading offers or invitations.
All content provided by XM and third-party suppliers on this website, including opinions, news, research, analysis, prices, other information, and third-party website links, remains unchanged and is provided as general market commentary rather than investment advice. All materials published on online trading platforms are only for educational/informational purposes and do not include or should be considered as applicable to financial, investment tax, or trading related advice and recommendations, or transaction price records, or any financial product or non invitation related financial offers or invitations. Please ensure that you have read and fully understood the information on XM's non independent investment research tips and risk warnings. For more details, please click here